Physicians' Academy for Cardiovascular Education
Report; CV Risk Management 2016 - Applying the latest insights to clinical care

Report; CV Risk Management 2016 - Applying the latest insights to clinical care

Yogyakarta, Java - Indonesia October 22, 2016

Oct. 24, 2016

This Master Class program is a global initiative of the PACE-CME foundation with a particular focus on issues and opportunities in cardiovascular risk and lipid management in high risk patients

Agenda & Faculty

Cardiovascular Disease: The ongoing journey to manage the risk - University College London, London, United Kingdom

Managing CV Risk in Indonesia: How well are we doing and where can we improve? - Anwar Santoso, MD, University of Indonesia, Jakarta, Indonesia

Managing lipids: Integrating novel insights with gold standard therapies - Philip Barter, MD, University of Sydney, Sydney, Australia

Blood pressure: How do recent trial outcomes impact our hypertension management? - Neil Poulter, MD, Imperial College London, United Kingdom

Guidance in CV Risk management: How to deal with international guidelines? - Philip Barter, MD, Sydney, Australia

CV Risk guidelines for Indonesia: What and how to follow? - Renan Sukmawan, MD, Harapan Kita National Cardiovascular Centre, Jakarta-Indonesia

T2DM & CVD: An update on current and new strategies improving outcomes - Neil Poulter, MD, Imperial College London, United Kingdom

Educational information

The overall educational objectives of the Cardiovascular Master Class were to:

CME accreditation

This Master Class was endorsed and accredited by the Indonesian Cardiology Association

Funding

The CV Risk Master Class was funded by an unrestricted educaional grant provided by Pfizer